Sol-Gel将向PellePharm支付470万美元的预付款,以及高达600万美元的开发和NDA验收里程碑,以及高达6400万美元的商业里程碑和分成。
Patidegib被Sol-Gel指定为SGT-610,用于治疗Go...查看全文
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-05-15 AccNo: 0001178913-18-001670 Size: 119 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-04-17 AccNo: 0001178913-18-001204 Size: 220 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-03-26 AccNo: 0001178913-18-000963 Size: 170 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Filed: 2018-03-26 AccNo: 0001178913-18-000960 Size: 6 MB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-03-22 AccNo: 0001178913-18-000924 Size: 15 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-02-26 AccNo: 0001178913-18-000687 Size: 146 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-02-26 AccNo: 0001178913-18-000685 Size: 12 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-02-15 AccNo: 0001178913-18-000597 Size: 122 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-02-12 AccNo: 0001178913-18-000468 Size: 72 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-12 AccNo: 0001178913-18-000432 Size: 181 KB 网页链接